Interaction and functional cooperation of NF-kappa B with Smads. Transcriptional regulation of the junB promoter
- PMID: 10874048
- DOI: 10.1074/jbc.M909923199
Interaction and functional cooperation of NF-kappa B with Smads. Transcriptional regulation of the junB promoter
Abstract
The transforming growth factor-beta (TGF-beta) family of cytokines regulates diverse cellular processes through control of the expression of target genes. Smad proteins are a recently identified family of signal transducers for members of the TGF-beta family. Smads act as transcriptional regulators through binding to DNA and interacting with a variety of transcription factors. Here, we identified a kappaB site as a TGF-beta-responsive region in the 3'-downstream junB promoter region. We also demonstrate that kappaB sites alone are sufficient to mediate immediate transcriptional activation by TGF-beta. Transactivation of kappaB sites by TGF-beta requires an intact NF-kappaB pathway, cooperates with known activators of this pathway, and is mediated by Smad family members. Furthermore, we show that Smad3 interacts with p52 in vivo. These data expand the model in which Smad proteins undergo multiple interactions with several transcription factors that could induce either activation or repression of gene expression.
Similar articles
-
Induction of the AP-1 members c-Jun and JunB by TGF-beta/Smad suppresses early Smad-driven gene activation.Oncogene. 2001 Apr 26;20(18):2205-11. doi: 10.1038/sj.onc.1204347. Oncogene. 2001. PMID: 11402315
-
Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.Int J Cancer. 2003 Jul 10;105(5):661-8. doi: 10.1002/ijc.11146. Int J Cancer. 2003. PMID: 12740915
-
Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner.Oncogene. 2001 Jun 7;20(26):3332-40. doi: 10.1038/sj.onc.1204448. Oncogene. 2001. PMID: 11423983
-
Transcriptional regulation by Smads: crosstalk between the TGF-beta and Wnt pathways.J Bone Joint Surg Am. 2001;83-A Suppl 1(Pt 1):S31-9. J Bone Joint Surg Am. 2001. PMID: 11263663 Review.
-
SIP1 (Smad interacting protein 1) and deltaEF1 (delta-crystallin enhancer binding factor) are structurally similar transcriptional repressors.J Bone Joint Surg Am. 2001;83-A Suppl 1(Pt 1):S40-7. J Bone Joint Surg Am. 2001. PMID: 11263664 Review.
Cited by
-
Signaling Cross Talk between TGF-β/Smad and Other Signaling Pathways.Cold Spring Harb Perspect Biol. 2017 Jan 3;9(1):a022137. doi: 10.1101/cshperspect.a022137. Cold Spring Harb Perspect Biol. 2017. PMID: 27836834 Free PMC article. Review.
-
Mechanisms balancing skeletal matrix synthesis and degradation.Biochem J. 2002 Jun 1;364(Pt 2):329-41. doi: 10.1042/BJ20020165. Biochem J. 2002. PMID: 12023876 Free PMC article. Review.
-
Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-κB and transforming growth factor-β1/Smad3 in diabetic nephropathy.Exp Biol Med (Maywood). 2010 Mar;235(3):383-91. doi: 10.1258/ebm.2009.009218. Exp Biol Med (Maywood). 2010. PMID: 20404057 Free PMC article.
-
Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-beta is mediated by a nuclear factor-kappaB site.Biochem J. 2004 Jul 15;381(Pt 2):413-22. doi: 10.1042/BJ20040058. Biochem J. 2004. PMID: 15086314 Free PMC article.
-
Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching.Am J Pathol. 2003 Feb;162(2):533-46. doi: 10.1016/s0002-9440(10)63847-3. Am J Pathol. 2003. PMID: 12547711 Free PMC article.
